Framingham, MA · Health Care · Form D filed Sep 10, 2026
Alzheon, Inc. raised $78.8M
Alzheon, Inc. is a biotechnology company based in Framingham, Massachusetts. In a Form D filed with the SEC on September 10, 2026, it reported raising $78,797,184 from 3 investors as part of an offering of up to $499,999,999. The first sale in the offering took place on August 26, 2026.
- 10th Form D since 2013. Earlier new notices: Mar 12, 2024 · Jan 11, 2023 · Sep 30, 2020 · Jan 15, 2020 · Jun 9, 2017 · Feb 26, 2016 and more. All filings on EDGAR
- Still raising. $421M of the $500M offering was still unsold at filing.
$215M raised since 2020
5 Form D offerings, as reported to the SEC, the first in Jan 15, 2020. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 10, 2026 | $78.8M | $500M | 3 |
| Mar 12, 2024 | $126M | $150M | 76 |
| Jan 11, 2023 | $1.7M | $50M | 6 |
| Sep 30, 2020 | $2.4M | $50M | 5 |
| Jan 15, 2020 | $6.2M | $6.2M | 13 |
Lead score
28 out of 100
still raising budget to spend
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $78,797,184
- Offering size
- $499,999,999
- Investors so far
- 3
- First sale
- August 26, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Framingham, Massachusetts
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $78,797,184 | $499,999,999 | 3 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 7, 2026 · Health Care funding in Massachusetts · September 2026 funding report
Similar raises
Netta Startup Studio LLC
Framingham, MA · filed Oct 2
Netta Startup Studio offers advisory and development services for early-stage startups, connecting innovation and investment across Israel and North America.
3rd Form D since 2025
Axelyf, Inc.
Chestnut Hill, MA · filed Oct 132nd Form D since 2025
Soterya, Inc.
Boston, MA · filed Oct 13First Form DStill raising
Bioventrix, Inc.
Mansfield, MA · filed Oct 8
OUR VISION: Extend Life Span and Improve Quality of Life for Heart Failure Patients OUR VISION Extending Life Span and Improving Quality of Life for Heart Failure Patients How Revivent Therapy May…
26th Form D since 2009Still raising
Revbio, Inc.
Lowell, MA · filed Oct 2
TETRANITE is a regenerative bone glue. Bioengineered for a body of applications, TETRANITE® promises to transform bone repair.
4th Form D since 2019
Opus KSD, Inc.
Pembroke, MA · filed Oct 13rd Form D since 2016
Xact Bio, Inc.
Boston, MA · filed Sep 28First Form DStill raising
Way Biosolutions, Inc.
Cambridge, MA · filed Sep 25First Form D